Column Group LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001833486 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 12, 2022

Total Value: $470M (100.0% shares, 0.0% debt)

Holdings (7)

— NGM Biopharmaceuticals Inc 49.5%

Value $233M Shares 18,136,735 Est. Cost $27.77 Unrealized —

RVMD Revolution Medicines Inc 18.2%

Value $85.66M Shares 4,395,050 Est. Cost $34.75 Unrealized -44.0%

TNYA Tenaya Therapeutics, Inc. 11.3%

Value $52.92M Shares 9,400,290 Est. Cost $21.49 Unrealized -62.3%

— RAPT Therapeutics Inc 10.4%

Value $48.92M Shares 2,680,458 Est. Cost $19.03 Unrealized —

— Surrozen, Inc. 5.9%

Value $27.75M Shares 9,248,129 Est. Cost $7.07 Unrealized —

ORIC ORIC Pharmaceuticals Inc. 3.4%

Value $15.98M Shares 3,568,181 Est. Cost $28.69 Unrealized -86.1%

— eFFECTOR Therapeutics Inc 1.3%

Value $6.119M Shares 4,309,329 Est. Cost $14.05 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	NGM Biopharmaceuticals Inc	18,136,735	$233M	49.5%	$27.77	—	COM	62921N105
RVMD	Revolution Medicines Inc	4,395,050	$85.66M	18.2%	$34.75	-44.0%	COM	76155X100
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$52.92M	11.3%	$21.49	-62.3%	COM	87990A106
—	RAPT Therapeutics Inc	2,680,458	$48.92M	10.4%	$19.03	—	COM	75382E109
—	Surrozen, Inc.	9,248,129	$27.75M	5.9%	$7.07	—	COM	86889P109
ORIC	ORIC Pharmaceuticals Inc.	3,568,181	$15.98M	3.4%	$28.69	-86.1%	COM	68622P109
—	eFFECTOR Therapeutics Inc	4,309,329	$6.119M	1.3%	$14.05	—	COM	28202V108